Argent Biopharma (H5O0) Income Statement
Argent Biopharma Income Statement
Last quarter (Q3 2025), Argent Biopharma's total revenue was $-5.16K, a decrease of 102.93% from the same quarter last year. In Q3, Argent Biopharma's net income was $-2.39M. See Argent Biopharma’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Jun 25 | Jun 24 | Jun 23 | Jun 22 | Jun 21 |
|---|---|---|---|---|---|
| $ 161.19K | $ 583.45K | $ 891.08K | $ 3.39M | $ 4.73M | |
| $ -204.21K | $ 446.32K | $ 203.70K | $ 1.45M | $ 1.81M | |
| $ 7.19M | $ 15.89M | $ 18.47M | $ 17.05M | $ 16.07M | |
| Depreciation and Amortization | $ 164.59K | $ 789.14K | $ 1.29M | $ 751.94K | $ 405.22K |
| $ -7.23M | $ -17.00M | $ -15.77M | $ -20.04M | $ -16.54M | |
| $ -7.39M | $ -15.44M | $ -18.26M | $ -15.60M | $ -14.26M | |
| $ -316.66K | $ -2.40M | $ 713.39K | $ -5.53M | $ -2.88M | |
| $ -7.71M | $ -17.84M | $ -17.55M | $ -21.13M | $ -17.14M | |
| $ -7.71M | $ -17.84M | $ -17.53M | $ -20.82M | $ -16.77M | |
| Per Share Metrics | |||||
| Basic EPS | $ -0.09 | $ -0.31 | $ -0.47 | $ -7.10 | $ -6.50 |
| Diluted EPS | $ -0.09 | $ -0.31 | $ -0.47 | $ -7.10 | $ -6.50 |
| Weighted Average Shares Outstanding | 86.72M | 57.17M | 37.01M | 2.94M | 2.57M |
| Weighted Average Shares Outstanding (Diluted) | 86.72M | 57.17M | 37.01M | 2.94M | 2.57M |
Currency in AUD
